Dr. Jeffrey R. Jay, M.D.

Latest statistics and disclosures from Great Point Partners's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Great Point Partners

Great Point Partners holds 34 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alpine Immune Sciences (ALPN) 12.0 $71M +20% 3.7M 19.06
 View chart
Cytokinetics Com New (CYTK) 7.1 $42M -16% 500k 83.49
 View chart
Urogen Pharma (URGN) 6.7 $39M 2.6M 15.00
 View chart
Pliant Therapeutics (PLRX) 5.6 $33M +3% 1.8M 18.11
 View chart
Ultragenyx Pharmaceutical (RARE) 5.3 $31M -10% 648k 47.82
 View chart
Xenon Pharmaceuticals (XENE) 4.7 $28M +19% 600k 46.06
 View chart
Rapt Therapeutics (RAPT) 4.7 $27M -24% 1.1M 24.85
 View chart
Alkermes SHS (ALKS) 4.1 $24M 875k 27.74
 View chart
Aerovate Therapeutics (AVTE) 4.0 $24M -4% 1.0M 22.63
 View chart
Vaxcyte (PCVX) 3.9 $23M -32% 360k 62.80
 View chart
Evolus (EOLS) 3.6 $21M -8% 2.0M 10.53
 View chart
Anaptysbio Inc Common (ANAB) 3.6 $21M +9% 977k 21.42
 View chart
Immunocore Hldgs Ads (IMCR) 3.4 $20M 293k 68.32
 View chart
Neurogene 3.3 $19M NEW 994k 19.38
 View chart
Amicus Therapeutics (FOLD) 3.1 $18M +49% 1.3M 14.19
 View chart
Tourmaline Bio 3.0 $18M NEW 673k 26.18
 View chart
Abivax Sa Sponsored Ads 2.8 $17M NEW 1.6M 10.70
 View chart
Zura Bio Class A Ord Shs (ZURA) 2.6 $15M 3.3M 4.67
 View chart
Optinose (OPTN) 1.9 $11M 8.8M 1.29
 View chart
Apogee Therapeutics (APGE) 1.9 $11M 400k 27.94
 View chart
Arvinas Ord (ARVN) 1.6 $9.6M NEW 234k 41.16
 View chart
Karuna Therapeutics Ord (KRTX) 1.6 $9.6M -50% 30k 316.51
 View chart
Vistagen Therapeutics Ord (VTGN) 1.6 $9.6M NEW 1.9M 5.14
 View chart
Terns Pharmaceuticals (TERN) 1.4 $8.5M +102% 1.3M 6.49
 View chart
Intra Cellular Therapies (ITCI) 1.4 $7.9M -50% 111k 71.62
 View chart
Sarepta Therapeutics (SRPT) 1.3 $7.7M -69% 80k 96.43
 View chart
Insmed Com Par $.01 (INSM) 1.2 $7.0M -42% 226k 30.99
 View chart
Puma Biotechnology (PBYI) 0.8 $4.7M NEW 1.1M 4.33
 View chart
Ocular Therapeutix (OCUL) 0.5 $3.1M NEW 700k 4.46
 View chart
Spyre Therapeutics Com New (SYRE) 0.5 $2.7M NEW 125k 21.52
 View chart
Arcellx Common Stock (ACLX) 0.5 $2.7M -83% 48k 55.50
 View chart
Merus N V (MRUS) 0.1 $550k NEW 20k 27.50
 View chart
Axsome Therapeutics (AXSM) 0.1 $395k NEW 5.0k 79.59
 View chart
Mural Oncology Pub Ord Shs 0.0 $68k NEW 12k 5.92
 View chart

Past Filings by Great Point Partners

SEC 13F filings are viewable for Great Point Partners going back to 2013

View all past filings